Sebela Pharmaceuticals Revenue and Competitors

Atlanta, GA Georgia

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Sebela Pharmaceuticals's estimated annual revenue is currently $51.9M per year.(i)
  • Sebela Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Sebela Pharmaceuticals has 258 Employees.(i)
  • Sebela Pharmaceuticals grew their employee count by -5% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2M20N/AN/AN/A
Add Company

Sebela Pharmaceuticals Inc. is committed to improving patients lives by developing, marketing and selling differentiated branded prescription pharmaceuticals that bring meaningful value to patients affected by gastrointestinal, dermatological and women's health diseases. To fulfill our commitment to improving patient's lives, we are continuing to grow our US commercial infrastructure, marketed product portfolio and late stage development pipeline in our core therapeutic areas. Our growth strategy includes in-licensing and acquiring late-stage drug candidates and marketed products that utilize and enhance our existing development and commercial capabilities. Sebela operates from two locations with an office in Roswell, Georgia, and headquarters in Dublin, Ireland.

keywords:Biotechnology,Healthcare,Pharmaceuticals

N/A

Total Funding

258

Number of Employees

$51.9M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Sebela Pharmaceuticals's People

NameTitleEmail/Phone
1
Head Corporate DevelopmentReveal Email/Phone
2
Pharmaceutical Sales RepresentativeReveal Email/Phone
3
Talent Acquisition Business PartnerReveal Email/Phone
4
Specialty Sales RepresentativeReveal Email/Phone
5
Senior Territory Sales ManagerReveal Email/Phone
6
VP Market AccessReveal Email/Phone
7
Accounting ManagerReveal Email/Phone
8
Manager, Clinical OperationsReveal Email/Phone
9
Sr Director Sales OperationsReveal Email/Phone
10
District ManagerReveal Email/Phone

Sebela Pharmaceuticals News

2022-04-19 - Paroxetine Market Size, Share, Growth 2022-2030| Key ...

Apotex; Sebela Pharmaceuticals; Teva; Mylan; Sun Pharmaceutical; Lupin; Lannett Company; Aurobindo; Jubilant Pharma; Sciecure Pharma. Paroxetine...

2022-04-17 - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs ...

The producers involved in the industry cover: Bausch Health; Allergan; Sebela Pharmaceuticals; Astellas Pharmaceuticals; Amneal Pharms; Pharscin Pharma. ACCESS...

2022-04-06 - HK inno.N says it confirmed K-Cab's safety in US trial

... subsidiary of Sebela Pharmaceuticals which focuses on gastroenterology. ... In China, Shandong Luoxin Pharmaceutical Group seeks to win...

2021-03-23 - CellMax Life and Sebela Pharmaceuticals Enter Strategic Development and Commercialization Partnership for FirstSight™ Blood Test for Detection of Colorectal Cancer and Pre-Cancer

SUNNYVALE, Calif. and ROSWELL, Ga., March 23, 2021 /PRNewswire/ -- CellMax Life, a molecular diagnostics company with proprietary technology for pre-cancer and cancer detection blood tests, and Sebela Pharmaceuticals, a market leader in gastroenterology, announce the closing of a strategic devel ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$73.3M2727%N/A
#2
$92.2M2897%N/A
#3
$127.9M31010%N/A
#4
$58.2M3211%N/A
#5
$121.4M3875%N/A

Sebela Pharmaceuticals Executives


NameTitle
Alan CookeChief Executive Officer and President
PARAIC McDONOGHChief Financial Officer
Victor ParkerChief Commercial Officer
Scott BriggsChief Commercial Officer
Sue HallChief Scientific Officer and Head of R&D
Scott BriggsChief Commercial Officer
Robert RaleighChief Operating Officer and General Counsel
Alan CookeChief Executive Officer and President
Stuart SedlackVice President Business Development
Adam RoyVice President - Sales Operations
Stan RussellVice President | Site Head of Quality
Sandra MatsumotoVice President, Regulatory Affairs & QA► FDA, Regulatory Strategy ★ Innovative Product Development
Kevin PetersVice President Clinical Affairs
Frank BlondinoVice President, CMC and Manufacturing Operations, Women's Health R&D
Shauna IgoeVP Group Finance
Donna D.VP Dermatology, Women's Health & Mature Brands
Sandra MatsumotoVice President, Regulatory Affairs ► FDA, Regulatory Strategy ★ Innovative Product Development
Genie MasseyVP, Senior Counsel
Jai WallVice President, Corporate Affairs
Tim CavicchiVice President, Sales, Gastroenterology